| Literature DB >> 29666405 |
Hao-Wei Chen1,2, Yu-Chen Chen1,2, Frances M Yang3, Wen-Jeng Wu2, Ching-Chia Li2, Yong-Yuan Chang4, Yii-Her Chou5.
Abstract
Numerous epidemiological studies have shown that male patients with uric acid nephrolithiasis outnumber female patients. To our knowledge, no research exists evaluating the reasons gender affects the development of uric acid nephrolithiasis. We hereby used a novel application of structural equation modeling to analyze the mediators of the effects of gender on uric acid nephrolithiasis. In 1,098 patients with nephrolithiasis between 2012 and 2016, male gender was found to have a statistically significant positive indirect effect on the development of uric acid nephrolithiasis, which was mediated by lower urine pH (estimate: 0.010, standard error: 0.005, critical ratio: 2.135, 95% confidence interval: 0.002-0.023, P = 0.017), lower estimated glomerular filtration rate (estimate: 0.014, standard error: 0.005, critical ratio: 2.993, 95% confidence interval: 0.006-0.025, P < 0.001), and higher incidence rate of gout (estimate: 0.009, standard error: 0.005, critical ratio: 2.028, 95% confidence interval: 0.002-0.021, P = 0.009). We conclude that low urine pH, impaired renal function, and gout are the mediators of the effect of male gender on the development of uric acid nephrolithiasis. The survey, treatment, and follow-up of kidney diseases, acidic urine, and uric acid metabolism disorders should be considered in men with uric acid nephrolithiasis.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29666405 PMCID: PMC5904184 DOI: 10.1038/s41598-018-24485-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Hypothesized model. Each path will have a starting point and arrowhead direction. The starting point variables represent independent variables (exposure factors). The arrowhead direction represents dependent variables (results).
Characteristics of 1098 patients with nephrolithiasis based on uric acid nephrolithiasis.
| Characteristic | Uric acid nephrolithiasis (n = 146) | Non-uric acid nephrolithiasis (n = 952) | |
|---|---|---|---|
| Age, mean (SD), year | 60.4 (12.6) | 52.8 (12.7) | <0.001 |
| Gender, No. (%) | 0.046 | ||
| Male | 110 (75) | 638 (67) | |
| BMI, mean (SD), kg/m2 | 25.6 (3.8) | 25.4 (3.5) | 0.27 |
| eGFR, mean (SD), ml/min/1.73 m2 | 55.1 (29.4) | 80.1 (29.4) | <0.001 |
| Stone symptoms, No. (%) | 0.22 | ||
| Asymptomatic | 9 (6.2) | 90 (9.5) | |
| Hypertension, No. (%) | 59 (40) | 236 (25) | <0.001 |
| Diabetes mellitus, No. (%) | 42 (29) | 122 (13) | <0.001 |
| Gout, No. (%) | 14 (9.6) | 21 (2.2) | <0.001 |
| Alcohol Consumption, No. (%) | 8 (5.5) | 98 (10) | 0.071 |
| Occupation, No. (%) | 0.42 | ||
| Working in heat environment | 21 (14) | 113 (12) | |
| Diet style, No. (%) | 0.9 | ||
| Western diet style | 32 (22) | 213 (22) | |
| Bacteriuria, No. (%) | 13 (8.9) | 164 (17) | 0.011 |
| Urine SG, mean (SD), g/dl3 | 1.014 (0.006) | 1.014 (0.007) | 0.9 |
| Urine pH, mean (SD) | 5.51 (0.54) | 6.09 (0.77) | <0.001 |
Abbreviations: SD, standard deviation; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity.
Characteristics of 146 patients with uric acid nephrolithiasis based on genders.
| Characteristic | Male (n = 110) | Female (n = 36) | |
|---|---|---|---|
| Age, mean (SD), year | 58.7 (12.6) | 65.9 (10.7) | 0.001 |
| BMI, mean (SD), kg/m2 | 25.9 (3.6) | 24.5 (4.2) | 0.12 |
| eGFR, mean (SD), ml/min/1.73 m2 | 56.2 (30.2) | 51.9 (27.6) | 0.48 |
| Stone symptoms, No. (%) | 1 | ||
| Asymptomatic | 7 (6.4) | 2 (5.6) | |
| Hypertension, No. (%) | 33 (30) | 26 (72) | <0.001 |
| Diabetes mellitus, No. (%) | 22 (20) | 20 (56) | <0.001 |
| Gout, No. (%) | 12 (11) | 2 (5.6) | 0.52 |
| Alcohol Consumption, No. (%) | 8 (7.3) | 0 (0) | 0.2 |
| Occupation, No. (%) | 0.002 | ||
| Working in heat environment | 21 (19) | 0 (0) | |
| Diet style, No. (%) | 0.001. | ||
| Western diet style | 31 (28) | 1 (2.8) | |
| Bacteriuria, No. (%) | 8 (7.3) | 5 (14) | 0.31 |
| Urine SG, mean (SD), g/dl3 | 1.014 (0.006) | 1.014 (0.006) | 0.8 |
| Urine pH, mean (SD) | 5.49 (0.55) | 5.58 (0.49) | 0.19 |
Abbreviations: SD, standard deviation; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity.
Characteristics of 952 patients with non-uric acid nephrolithiasis based on genders.
| Characteristic | Male (n = 638) | Female (n = 314) | |
|---|---|---|---|
| Age, mean (SD), year | 51.1 (12.4) | 56.1 (12.8) | <0.001 |
| BMI, mean (SD), kg/m2 | 25.4 (3.4) | 25.4 (3.9) | 0.78 |
| eGFR, mean (SD), ml/min/1.73 m2 | 80.8 (28.4) | 78.8 (31.3) | 0.17 |
| Stone symptoms, No. (%) | 0.9 | ||
| Asymptomatic | 61 (9.6) | 29 (9.2) | |
| Hypertension, No. (%) | 147 (23) | 89 (28) | 0.08 |
| Diabetes mellitus, No. (%) | 77 (12) | 45 (14) | 0.35 |
| Gout, No. (%) | 20 (3.1) | 1 (0.3) | 0.004 |
| Alcohol Consumption, No. (%) | 94 (15) | 4 (1.3) | <0.001 |
| Occupation, No. (%) | <0.001 | ||
| Working in heat environment | 105 (16) | 8 (2.5) | |
| Diet style, No. (%) | <0.001 | ||
| Western diet style | 174 (27) | 39 (12) | |
| Bacteriuria, No. (%) | 74 (12) | 90 (29) | <0.001 |
| Urine SG, mean (SD), g/dl3 | 1.015 (0.006) | 1.013 (0.006) | <0.001 |
| Urine pH, mean (SD) | 6.04 (0.74) | 6.19 (0.82) | 0.014 |
Abbreviations: SD, standard deviation; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity.
Figure 2Best-fitting model with statiscally significant pathways and standarized estimates. *Abbreviations: HT, hypertension; DM, diabetes mellitus; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity. *Correlations and measure errors of each parameter are hidden in the figure to avoid chaotic representation. aUric acid nephrolithiasis versus non-uric acid nephrolithiasis. bMale gender versus female gender.
Statistically significant direct effects between the parameters.
| Direct effects | Estimatec | SE | CR | 95% CI |
|
|---|---|---|---|---|---|
| Urine pH → Uric acid nephrolithiasisa | −0.217 | 0.024 | −9.065 | −0.263 ~ −0.169 | <0.001 |
| Gout → Uric acid nephrolithiasisa | 0.101 | 0.043 | 2.375 | 0.018 ~ 0.183 | 0.016 |
| Bacteriuria → Uric acid nephrolithiasisa | −0.075 | 0.022 | −3.369 | −0.117 ~ −0.030 | 0.003 |
| DM → Uric acid nephrolithiasisa | 0.097 | 0.035 | 2.753 | 0.030 ~ 0.167 | 0.001 |
| eGFR → Uric acid nephrolithiasisa | −0.227 | 0.028 | −8.225 | −0.280 ~ −0.173 | <0.001 |
| Maleb → Urine pH | −0.073 | 0.032 | −2.299 | −0.135 ~ −0.011 | 0.018 |
| Maleb → Bacteriuria | −0.196 | 0.032 | −6.206 | −0.260 ~ −0.134 | <0.001 |
| Maleb → Gout | 0.127 | 0.031 | 4.038 | 0.077 ~ 0.205 | <0.001 |
| Maleb → eGFR | −0.087 | 0.026 | −3.391 | −0.138 ~ −0.038 | <0.001 |
| Maleb → Urine SG | 0.103 | 0.033 | 3.151 | 0.036 ~ 0.166 | 0.003 |
| Maleb → Alcohol Consumption | 0.189 | 0.031 | 10.782 | 0.152 ~ 0.221 | <0.001 |
| Maleb → Occupation | 0.174 | 0.020 | 8.570 | 0.132 ~ 0.211 | <0.001 |
| Maleb → Diet style | 0.131 | 0.026 | 5.014 | 0.077 ~ 0.181 | <0.001 |
| Age → HT | 0.223 | 0.027 | 8.387 | 0.172 ~ 0.274 | <0.001 |
| Age → DM | 0.178 | 0.028 | 6.361 | 0.122 ~ 0.232 | <0.001 |
| Age → BMI | −0.083 | 0.031 | −2.626 | −0.144 ~ −0.021 | 0.009 |
| Age → eGFR | −0.603 | 0.021 | −29.111 | −0.643 ~ −0.561 | <0.001 |
| Age → Diet style | −0.174 | 0.029 | −5.970 | −0.229 ~ −0.114 | 0.001 |
| Age → Occupation | −0.077 | 0.029 | −2.692 | −0.133 ~ −0.020 | 0.009 |
| Urine SG → Urine pH | −0.191 | 0.030 | −6.386 | −0.249 ~ −0.131 | <0.001 |
| BMI → Urine pH | −0.107 | 0.030 | −3.575 | −0.165 ~ −0.048 | 0.001 |
| DM → Urine pH | −0.061 | 0.028 | −2.155 | −0.117 ~ −0.007 | 0.03 |
| eGFR → Urine pH | 0.167 | 0.030 | 5.578 | 0.107 ~ 0.223 | 0.001 |
| Bacteriuria → Urine pH | 0.090 | 0.031 | 2.947 | 0.029 ~ 0.150 | 0.005 |
| Bacteriuria → Urine SG | 0.070 | 0.030 | 2.316 | 0.011 ~ 0.131 | 0.018 |
| HT → Bacteriuria | 0.108 | 0.032 | 3.367 | 0.045 ~ 0.173 | 0.001 |
| Asymptomatic → Urine SG | −0.078 | 0.026 | −2.998 | −0.128 ~ −0.024 | 0.003 |
| Alcohol Consumption → Diet style | 0.088 | 0.034 | 2.565 | 0.021 ~ 0.158 | 0.008 |
| Alcohol Consumption → Occupation | 0.101 | 0.040 | 2.506 | 0.025 ~ 0.184 | 0.009 |
Abbreviations: SE, standard error; CR, critical ratio; CI, confidence interval; P, two tailed P value; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity; DM, diabetes mellitus; HT, hypertension.
aUric acid nephrolithiasis versus non-uric acid nephrolithiasis.
bMale gender versus female gender.
cStandardized estimate.
Statistically significant correlations between the parameters.
| Correlations | Estimateb | SE | CR | 95% CI |
| |
|---|---|---|---|---|---|---|
| Age | Malea | −0.173 | 0.029 | −5.983 | −0.229 ~ −0.116 | <0.001 |
| Bacteriuria | Asymptomatic | 0.155 | 0.039 | 3.941 | 0.078 ~ 0.232 | <0.001 |
| BMI | Diet style | 0.056 | 0.023 | 2.402 | 0.011 ~ 0.101 | 0.015 |
| BMI | HT | 0.144 | 0.031 | 4.875 | 0.087 ~ 0.203 | <0.001 |
| BMI | DM | 0.110 | 0.029 | 3.789 | 0.056 ~ 0.168 | <0.001 |
| BMI | eGFR | 0.263 | 0.032 | 8.160 | 0.197 ~ 0.322 | <0.001 |
| DM | Alcohol Consumption | 0.105 | 0.034 | 3.007 | 0.041 ~ 0.178 | 0.002 |
| DM | Asymptomatic | 0.120 | 0.038 | 3.188 | 0.047 ~ 0.194 | 0.001 |
| DM | HT | 0.357 | 0.032 | 10.666 | 0.293 ~ 0.422 | <0.001 |
| Diet style | Asymptomatic | 0.082 | 0.035 | 2.387 | 0.016 ~ 0.149 | 0.014 |
| Diet style | Occupation | 0.608 | 0.028 | 21.922 | 0.552 ~ 0.661 | <0.001 |
| HT | Asymptomatic | 0.114 | 0.034 | 3.349 | 0.046 ~ 0.180 | <0.001 |
| HT | Alcohol Consumption | 0.085 | 0.033 | 2.635 | 0.021 ~ 0.148 | 0.013 |
Abbreviations: SE, standard error; CR, critical ratio; CI, confidence interval; P, two tailed P value; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity; DM, diabetes mellitus; HT, hypertension.
aMale gender versus female gender.
bStandardized estimate.
Statistically significant specific indirect effects between the parameters.
| Specific indirect effects | Estimatec | SE | CR | 95% CI |
|
|---|---|---|---|---|---|
| Maleb → Bacteriuria → Uric acid nephrolithiasisa | 0.011 | 0.004 | 2.891 | 0.004 ~ 0.019 | 0.002 |
| Maleb → Gout → Uric acid nephrolithiasisa | 0.009 | 0.005 | 2.028 | 0.002 ~ 0.021 | 0.009 |
| Maleb → Urine pH → Uric acid nephrolithiasisa | 0.011 | 0.005 | 2.135 | 0.002 ~ 0.023 | 0.017 |
| Maleb → eGFR → Uric acid nephrolithiasisa | 0.014 | 0.005 | 2.993 | 0.006 ~ 0.025 | <0.001 |
| Maleb → Bacteriuria → Urine pH → Uric acid nephrolithiasisa | 0.003 | 0.001 | 2.452 | 0.001 ~ 0.006 | 0.004 |
| Maleb → eGFR → Urine pH → Uric acid nephrolithiasisa | 0.002 | 0.001 | 2.668 | 0.001 ~ 0.004 | <0.001 |
| Age → eGFR → Uric acid nephrolithiasisa | 0.004 | 0.001 | 7.218 | 0.003 ~ 0.005 | <0.001 |
| BMI → Urine pH → Uric acid nephrolithiasisa | 0.002 | 0.001 | 3.145 | 0.001 ~ 0.004 | 0.001 |
| DM → Urine pH → Uric acid nephrolithiasisa | 0.013 | 0.006 | 2.056 | 0.002 ~ 0.026 | 0.026 |
Abbreviations: SE, standard error; CR, critical ratio; CI, confidence interval; P, two tailed P value; BMI, body mass index; eGFR, estimated glomerular filtration rate; SG, specific gravity; DM, diabetes mellitus; HT, hypertension.
aUric acid nephrolithiasis versus non-uric acid nephrolithiasis.
bMale gender versus female gender.
cStandardized estimate.